IM Cannabis Corp. Common Shares (IMCC)
IMCC trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1792030/000117891326001877/0001178913-26-001877-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), period ending 2025-12-31. Converted from CAD at 1.4219 per USD (ECB reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | IMCC on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001792030 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Incorporated in | A1 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $38.5M |
| Net income | -$8.0M |
| Operating income | Not in SEC XBRL data |
| Net margin | -20.7% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.1× |
Reported in CAD; shown in US dollars.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | F-3 | 2026-10-08 |
| Latest annual report | 20-F | 2026-03-30 |
| Latest quarterly / interim | 6-K | 2026-10-02 |
Source: SEC EDGAR submissions feed, 300 recent filings. All filings on EDGAR.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AKAN | Akanda Corp. Common Shares | $1.38 | -15.85% | $3.3M |
| NAII | Natural Alternatives International Inc. | $1.15 | -5.74% | $7.2M |
| BON | Bon Natural Life Limited | $1.12 | -0.76% | $9.1M |
| XXII | 22nd Century Group Inc. | $0.6666 | -7.98% | $476K |
| MTEX | Mannatech Incorporated | $7.56 | -2.95% | $14.6M |
| BTMD | Biote Corp. | $1.04 | -8.77% | $37.4M |
| ISPR | Ispire Technology Inc. | $1.45 | -1.36% | $83.7M |
| FTLF | FitLife Brands Inc. | $9.07 | -1.73% | $85.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier